Please enable JavaScript to continue using this application.

Compare $MGNX vs $QTTB | Chartloom

Compare

$MGNX vs $QTTB

MacroGenics Inc · Q32 Bio Inc

MGNX

MacroGenics Inc

QTTB

Q32 Bio Inc

Compare $MGNX vs $QTTB

Comparing MacroGenics Inc and Q32 Bio Inc

MGNXMacroGenics Inc

QTTBQ32 Bio Inc

MGNXMacroGenics Inc

Market cap

$238M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.39x

Rev growth (TTM)

1.3%

YTD performance

132.3%

52W performance

110.1%

FCF yield

-27.6%

QTTBQ32 Bio Inc

Market cap

$248M

P/E (TTM)

8.22x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

142.4%

52W performance

178.9%

FCF yield

-8.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MGNX

QTTB

Detailed metrics comparison

MGNX

MacroGenics Inc

QTTB

Q32 Bio Inc

Market Cap

MGNX$238M

QTTB$248M

Enterprise Value

MGNX$302M

QTTB$142M

Price

MGNX$3.74

QTTB$8.34

P/E Ratio

MGNXN/A

QTTB8.22x

P/S Ratio

MGNX1.42x

QTTB4.62x

EV/Sales

MGNX1.80x

QTTB2.64x

EV/EBITDA

MGNX5.31x

QTTB3.69x

P/B Ratio

MGNX5.32x

QTTB2.31x

P/FCF Ratio

MGNXN/A

QTTBN/A

EV/FCF

MGNX-4.61x

QTTB-7.16x

PEG Ratio

MGNXN/A

QTTBN/A

Forward P/E (NTM)

MGNXN/A

QTTBN/A

Forward P/S (NTM)

MGNX2.39x

QTTBN/A

Revenue (TTM)

MGNX$168M

QTTB$54M

Revenue Growth (YoY)

MGNX1.3%

QTTBN/A

Forward Rev Growth

MGNX-12.8%

QTTB215.1%

Gross Margin (TTM)

MGNX61.8%

QTTB0.0%

Operating Margin (TTM)

MGNX0.0%

QTTB85.4%

EBITDA Margin (TTM)

MGNX-20.8%

QTTB71.6%

Net Margin (TTM)

MGNX-8.7%

QTTB93.7%

FCF Margin (TTM)

MGNX-39.1%

QTTB-36.9%

Net Income (TTM)

MGNX$-15M

QTTB$50M

FCF (TTM)

MGNX$-66M

QTTB$-20M

EPS (TTM)

MGNX-$0.23

QTTB$0.00

ROE (TTM)

MGNX-3127.0%

QTTB137.4%

ROA (TTM)

MGNX-535.0%

QTTB45.1%

ROIC (TTM)

MGNX-1017.0%

QTTB111.6%

Cash

MGNX$114M

QTTB$106M

Debt

MGNX$178M

QTTB$0

Net Cash/Debt

MGNX$-64M

QTTB$106M

Current Ratio (TTM)

MGNX2.96x

QTTB20.30x

Quick Ratio (TTM)

MGNX2.92x

QTTB19.80x

Debt/Equity (TTM)

MGNX4.16x

QTTB2.29x

Debt/Assets (TTM)

MGNX0.0%

QTTB0.0%

Interest Coverage (TTM)

MGNXN/A

QTTBN/A

Net Debt/EBITDA (TTM)

MGNX0.00x

QTTB0.00x

Beta

MGNX1.25

QTTB0.50

52W Performance

MGNX110.1%

QTTB178.9%

YTD Performance

MGNX132.3%

QTTB142.4%

% from 52W High

MGNX-26.4%

QTTB-64.6%

% from 52W Low

MGNX189.9%

QTTB337.8%

Asset Turnover (TTM)

MGNX0.61x

QTTB0.87x

FCF Yield (TTM)

MGNX-27.6%

QTTB-8.0%

Earnings Yield (TTM)

MGNX-6.1%

QTTB20.3%

Dividend Yield (TTM)

MGNXN/A

QTTBN/A

Rule of 40

MGNX-37.8

QTTB-36.9

EV/GP/RG

MGNXN/A

QTTBN/A

Ticker research

View MGNX research View QTTB research

Metric	MGNX MacroGenics Inc	QTTB Q32 Bio Inc
Market & Valuation
Market Cap	$238M	$248M
Enterprise Value	$302M	$142M
Price	$3.74	$8.34
P/E Ratio	N/A	8.22x
P/S Ratio	1.42x	4.62x
EV/Sales	1.80x	2.64x
EV/EBITDA	5.31x	3.69x
P/B Ratio	5.32x	2.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.61x	-7.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.39x	N/A
Revenue & Growth
Revenue (TTM)	$168M	$54M
Revenue Growth (YoY)	1.3%	N/A
Forward Rev Growth	-12.8%	215.1%
Profitability
Gross Margin (TTM)	61.8%	0.0%
Operating Margin (TTM)	0.0%	85.4%
EBITDA Margin (TTM)	-20.8%	71.6%
Net Margin (TTM)	-8.7%	93.7%
FCF Margin (TTM)	-39.1%	-36.9%
Net Income (TTM)	$-15M	$50M
FCF (TTM)	$-66M	$-20M
EPS (TTM)	-$0.23	$0.00
ROE (TTM)	-3127.0%	137.4%
ROA (TTM)	-535.0%	45.1%
ROIC (TTM)	-1017.0%	111.6%
Financial Health
Cash	$114M	$106M
Debt	$178M	$0
Net Cash/Debt	$-64M	$106M
Current Ratio (TTM)	2.96x	20.30x
Quick Ratio (TTM)	2.92x	19.80x
Debt/Equity (TTM)	4.16x	2.29x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.25	0.50
52W Performance	110.1%	178.9%
YTD Performance	132.3%	142.4%
% from 52W High	-26.4%	-64.6%
% from 52W Low	189.9%	337.8%
Efficiency & Yields
Asset Turnover (TTM)	0.61x	0.87x
FCF Yield (TTM)	-27.6%	-8.0%
Earnings Yield (TTM)	-6.1%	20.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-37.8	-36.9
EV/GP/RG	N/A	N/A
Ticker research	View MGNX research	View QTTB research

Valuation

P/E Ratio

QTTB

8.22x

P/S Ratio

MGNX

1.42x

QTTB

4.62x

EV/FCF

QTTB

-7.16x

MGNX

-4.61x

Growth & revenue

Revenue Growth TTM

MGNX

1.3%

Forward Revenue Growth

QTTB

215.1%

MGNX

-12.8%

Profitability & performance

Gross Margin

MGNX

61.8%

QTTB

0.0%

ROE

QTTB

137.4%

MGNX

-3127.0%

FCF Yield %

QTTB

-8.0%

MGNX

-27.6%

52-Week Performance

QTTB

178.9%

MGNX

110.1%

Detailed metrics comparison

MGNX

MacroGenics Inc

QTTB

Q32 Bio Inc

Market Cap

MGNX$238M

QTTB$248M

Enterprise Value

MGNX$302M

QTTB$142M

Price

MGNX$3.74

QTTB$8.34

P/E Ratio

MGNXN/A

QTTB8.22x

P/S Ratio

MGNX1.42x

QTTB4.62x

EV/Sales

MGNX1.80x

QTTB2.64x

EV/EBITDA

MGNX5.31x

QTTB3.69x

P/B Ratio

MGNX5.32x

QTTB2.31x

P/FCF Ratio

MGNXN/A

QTTBN/A

EV/FCF

MGNX-4.61x

QTTB-7.16x

PEG Ratio

MGNXN/A

QTTBN/A

Forward P/E (NTM)

MGNXN/A

QTTBN/A

Forward P/S (NTM)

MGNX2.39x

QTTBN/A

Revenue (TTM)

MGNX$168M

QTTB$54M

Revenue Growth (YoY)

MGNX1.3%

QTTBN/A

Forward Rev Growth

MGNX-12.8%

QTTB215.1%

Gross Margin (TTM)

MGNX61.8%

QTTB0.0%

Operating Margin (TTM)

MGNX0.0%

QTTB85.4%

EBITDA Margin (TTM)

MGNX-20.8%

QTTB71.6%

Net Margin (TTM)

MGNX-8.7%

QTTB93.7%

FCF Margin (TTM)

MGNX-39.1%

QTTB-36.9%

Net Income (TTM)

MGNX$-15M

QTTB$50M

FCF (TTM)

MGNX$-66M

QTTB$-20M

EPS (TTM)

MGNX-$0.23

QTTB$0.00

ROE (TTM)

MGNX-3127.0%

QTTB137.4%

ROA (TTM)

MGNX-535.0%

QTTB45.1%

ROIC (TTM)

MGNX-1017.0%

QTTB111.6%

Cash

MGNX$114M

QTTB$106M

Debt

MGNX$178M

QTTB$0

Net Cash/Debt

MGNX$-64M

QTTB$106M

Current Ratio (TTM)

MGNX2.96x

QTTB20.30x

Quick Ratio (TTM)

MGNX2.92x

QTTB19.80x

Debt/Equity (TTM)

MGNX4.16x

QTTB2.29x

Debt/Assets (TTM)

MGNX0.0%

QTTB0.0%

Interest Coverage (TTM)

MGNXN/A

QTTBN/A

Net Debt/EBITDA (TTM)

MGNX0.00x

QTTB0.00x

Beta

MGNX1.25

QTTB0.50

52W Performance

MGNX110.1%

QTTB178.9%

YTD Performance

MGNX132.3%

QTTB142.4%

% from 52W High

MGNX-26.4%

QTTB-64.6%

% from 52W Low

MGNX189.9%

QTTB337.8%

Asset Turnover (TTM)

MGNX0.61x

QTTB0.87x

FCF Yield (TTM)

MGNX-27.6%

QTTB-8.0%

Earnings Yield (TTM)

MGNX-6.1%

QTTB20.3%

Dividend Yield (TTM)

MGNXN/A

QTTBN/A

Rule of 40

MGNX-37.8

QTTB-36.9

EV/GP/RG

MGNXN/A

QTTBN/A

Ticker research

View MGNX research View QTTB research

Metric	MGNX MacroGenics Inc	QTTB Q32 Bio Inc
Market & Valuation
Market Cap	$238M	$248M
Enterprise Value	$302M	$142M
Price	$3.74	$8.34
P/E Ratio	N/A	8.22x
P/S Ratio	1.42x	4.62x
EV/Sales	1.80x	2.64x
EV/EBITDA	5.31x	3.69x
P/B Ratio	5.32x	2.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.61x	-7.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.39x	N/A
Revenue & Growth
Revenue (TTM)	$168M	$54M
Revenue Growth (YoY)	1.3%	N/A
Forward Rev Growth	-12.8%	215.1%
Profitability
Gross Margin (TTM)	61.8%	0.0%
Operating Margin (TTM)	0.0%	85.4%
EBITDA Margin (TTM)	-20.8%	71.6%
Net Margin (TTM)	-8.7%	93.7%
FCF Margin (TTM)	-39.1%	-36.9%
Net Income (TTM)	$-15M	$50M
FCF (TTM)	$-66M	$-20M
EPS (TTM)	-$0.23	$0.00
ROE (TTM)	-3127.0%	137.4%
ROA (TTM)	-535.0%	45.1%
ROIC (TTM)	-1017.0%	111.6%
Financial Health
Cash	$114M	$106M
Debt	$178M	$0
Net Cash/Debt	$-64M	$106M
Current Ratio (TTM)	2.96x	20.30x
Quick Ratio (TTM)	2.92x	19.80x
Debt/Equity (TTM)	4.16x	2.29x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.25	0.50
52W Performance	110.1%	178.9%
YTD Performance	132.3%	142.4%
% from 52W High	-26.4%	-64.6%
% from 52W Low	189.9%	337.8%
Efficiency & Yields
Asset Turnover (TTM)	0.61x	0.87x
FCF Yield (TTM)	-27.6%	-8.0%
Earnings Yield (TTM)	-6.1%	20.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-37.8	-36.9
EV/GP/RG	N/A	N/A
Ticker research	View MGNX research	View QTTB research